madman
Super Moderator
* They unpack the myths, the mechanisms, and the real impact behind these breakthrough therapies, and don’t shy away from the harder questions around access, affordability
From Hollywood headlines to hospital hallways, the world’s sudden fascination with GLP-1s makes it hard to separate fact from fiction. In this episode, Dr. Scott Sigman sits down with Dr. Robert Kushner, a pioneer in obesity medicine, professor at Northwestern University, and founding figure of the American Board of Obesity Medicine.
Together, they trace the unlikely origins of the GLP-1 revolution and explore how decades of research led to medications transforming weight management, metabolic health, and even heart and brain outcomes. They unpack the myths, the mechanisms, and the real impact behind these breakthrough therapies, and don’t shy away from the harder questions around access, affordability. Tune in to discover why the future of obesity care isn’t just about losing weight, it’s about gaining understanding.
From Hollywood headlines to hospital hallways, the world’s sudden fascination with GLP-1s makes it hard to separate fact from fiction. In this episode, Dr. Scott Sigman sits down with Dr. Robert Kushner, a pioneer in obesity medicine, professor at Northwestern University, and founding figure of the American Board of Obesity Medicine.
Together, they trace the unlikely origins of the GLP-1 revolution and explore how decades of research led to medications transforming weight management, metabolic health, and even heart and brain outcomes. They unpack the myths, the mechanisms, and the real impact behind these breakthrough therapies, and don’t shy away from the harder questions around access, affordability. Tune in to discover why the future of obesity care isn’t just about losing weight, it’s about gaining understanding.
